Clinical trial · Interventional

Effect of FDG-PET/CT for Simulation and Radiation Treatment Planning in Oral Cancer Patients

Phrase II Single Arm Study of Effect of FDG-PET/CT for Simulation and Radiation Treatment Planning in Oral

NCT03008694CI-TRIAL-00025319unknownPhase 2ClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

This study evaluates the effect of FDG-PET/CT for Simulation and Radiation Treatment Planning in oral Cancer patients. Progress-free survival (PFS) will be compared with historical control as defined in the protocol

Conditions

Conditions (2)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Oral Cancer	Malignant Lip and Oral Cavity Neoplasm	CURATED_BROADER	0.80
Radiotherapy; Complications	—	UNRESOLVED	—

Interventions

Interventions (1)

Intervention	Type	Mapped drug	Match
PET/CT	Device	—	UNRESOLVED

Design

Arms and outcomes

Arms (1)

type
EXPERIMENTAL
label
1
description
PET/CT
interventionNames
1. Device: PET/CT

Primary outcomes (1)

measure
progress free survival
timeFrame
baseline to 2 years

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years

Show eligibility criteria text

Inclusion Criteria:

* Histologically confirmed oral squamous-cell carcinoma
* Age \> 17 years
* Signed informed consent
* ECOG Performance status 0-2
* Must be able to start RT within 4 weeks after PET/CT simulation

Exclusion Criteria:

* stage IV disease diagnosed before acquisition of staging PET/CT
* prior radiotherapy to oral and neck
* Unable to understand study participation
* Claustrophobia
* pregnant or breast feeding mothers

References

Publications (0)

Data not yet available

No reference posted for this study.